Associated Banc Corp Sage Therapeutics, Inc. Transaction History

Associated Banc Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$70.65 - $96.76 $1,271 - $1,741	-18 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $616 - $936	-15 Reduced 45.45%	18 $1,000
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $363 - $604	-14 Reduced 29.79%	33 $1,000
Q1 2020 May 14, 2020	BUY	$26.15 - $77.24 $1,229 - $3,630	47 New	47 $1,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $330M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

Stay updated on Associated Banc Corp with notifications on news.